Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > EOD

<< Previous

Bullboard Posts

Next >>

Comment by inthestockgameon Jul 18, 2018 3:29pm

140 Views

Post# 28334671

RE:RE:EOD

I agree. The news did not reflect the trading activity and there was no HUGE run made prior or after the fact....which leads me to believe the run that we all thought was going to happen is yet to happen. Us reaching 27.5 as a 52 week high could have been anticipation. Lets get there again and beyond!!

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing